ScholarLens Back to search
2011•Journal of psychiatryRequires access

A comparative study of escitalopram augmented with olanzapine in the treatment of refractory depression

Yuyan Jiang

Open publisher page 0 citations

Abstract

Objective To investigate the efficacy of escitalopram combined with olanzapine in the treatment of refractory depression.Methods A total of 55 patients were randomly divided into study group treated with escitalopram combined with olanzapine and control group treated with olanzapine for 12 weeks.The efficacy and side effects were evaluated with Hamilton Depression Rating Scale(HAMD) and Treatment Emergent Symptom Scale(TESS).Results Scores of HAMD in two groups both decreased significantly(P0.05) after the treatment.Scores of HAMD in study group were significantly lower than that in control group at the 8th and 12th weekend(P0.05).Side effects in the two groups were mild,but the frequency of weigh gain and hypersomnia in study group were significantly higher than those in control study(P0.05).Conclusion Escitalopram augmented with olanzapine has better effect than escitalopram monotherapy in the treatment of refractory depression with satisfactory tolerability.

About this research paper

What this paper is about

Objective To investigate the efficacy of escitalopram combined with olanzapine in the treatment of refractory depression.Methods A total of 55 patients were randomly divided into study group treated with escitalopram combined with olanzapine and control group treated with olanzapine for 12 weeks.The efficacy and side effects were evaluated with Hamilton Depression Rating Scale(HAMD) and Treatment Emergent Symptom Scale(TESS).Results Scores of HAMD in two groups both decreased significantly(P0.05) after the treatment.Scores of HAMD in study group were significantly lower than that in control group at the 8th and 12th weekend(P0.05).Side effects in the two groups were mild,but the frequency of weigh gain and hypersomnia in study group were significantly higher than those in control study(P0.05).Conclusion Escitalopram augmented with olanzapine has better effect than escitalopram monotherapy in the treatment of refractory depression with satisfactory tolerability.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the efficacy of escitalopram combined with olanzapine in the treatment of refractory depression.Methods A total of 55 patients were randomly divided into study group treated with escitalopram combined with olanzapine and control group treated with olanzapine for 12 weeks.The efficacy and side effects were evaluated with Hamilton Depression Rating Scale(HAMD) and Treatment Emergent Symptom Scale(TESS).Results Scores of HAMD in two groups both decreased significantly(P0.05) after the treatment.Scores of HAMD in study group were significantly lower than that in control group at the 8th and 12th weekend(P0.05).Side effects in the two groups were mild,but the frequency of weigh gain and hypersomnia in study group were significantly higher than those in control study(P0.05).Conclusion Escitalopram augmented with olanzapine has better effect than escitalopram monotherapy in the treatment of refractory depression with satisfactory tolerability.

Key concepts: Escitalopram, Hamd, Olanzapine, Tolerability, Depression (economics), Refractory (planetary science), Internal medicine, Psychology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
A comparative study of escitalopram augmented with olanzapine in the treatment of refractory depression — Research Paper | ScholarLens